Metoprolol Succinate

• CAT Number: I005728
• CAS Number: 98418-47-4
• Molecular Formula: C34H56N2O10
• Molecular Weight: 652.82
• Purity: ≥95%
• Synonyms: 1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol hemisuccinate
• Target: Adrenergic Receptor
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IUPAC Name: butanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
• InChI: InChI=1S/2C15H25NO3.C4H6O4/c2*1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3;5-3(6)1-2-4(7)8/h2*4-7,12,14,16-17H,8-11H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
• InChIKey: RGHAZVBIOOEVQX-UHFFFAOYSA-N
• SMILES: CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(CC(=O)O)C(=O)O

Metoprolol Succinate（Cat No.:I005728）is a long-acting, cardioselective beta-1 adrenergic receptor blocker used to treat hypertension, angina, and heart failure. By selectively blocking beta-1 receptors in the heart, it reduces heart rate, myocardial oxygen demand, and blood pressure, helping to prevent heart attacks and manage chronic heart conditions. Metoprolol Succinate is often preferred for its sustained-release formulation, allowing for once-daily dosing with consistent therapeutic effects. It is widely used in cardiovascular therapy for improving survival rates in heart failure patients and reducing the risk of cardiovascular events.

Reference

[1]. Benfield P, et al. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders. Drugs. 1986 May;31(5):376-429.